Contact lens suitable for those with allergies

Article

Switching patients to 1-day disposable contact lenses (CLs) may improve lens-wearing comfort for those who have seasonal allergic conjunctivitis, according to CooperVision.

Key Points

Fairport, NY-Switching patients to 1-day disposable contact lenses (CLs) may improve lens-wearing comfort for those who have seasonal allergic conjunctivitis, according to CooperVision. Wearing new lenses each day means that allergens have less time to build up on the lens surface, minimizing allergic response.

"The two best options for CL wearers who experience allergic reactions and would like to continue wearing their contacts during those times are pharmacological therapy and the utilization of 1-day disposable lenses," said Harvard Sylvan, OD, director of professional relations for CooperVision.

"As lens dehydration and protein deposition can occur during the course of the day even with daily disposables, a material that resists both deposits and dehydration is preferable," Dr. Sylvan added.

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.